\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ none\\ \\-\\ incidental\\ finding\\,\\ if\\ less\\ than\\ 4\\ cm\\ unlikely\\ to\\ hemorrhage\\.\\ large\\ or\\ symptomatic\\ lesions\\ are\\ resected\\ or\\ embolized\\.\ \(0\)\
\-\ axial\\ ct\\ image\\ through\\ the\\ kidneys\\ without\\ and\\ with\\ iv\\ contrast\\ demonstrates\\ a\\ large\\ heterogeneous\\ exophytic\\ mass\\ in\\ the\\ mid\\ pole\\ of\\ the\\ left\\ kidney\\ with\\ focal\\ regions\\ of\\ hypodensity\\ corresponding\\ to\\ macroscopic\\ fat\\.\\ \\ the\\ lesion\\ enhances\\ heterogeneously\\ and\\ displaces\\ the\\ renal\\ parenchyma\\.\\ \\ there\\ is\\ stranding\\ of\\ the\\ perirenal\\ fat\\.\ \(0\)\
\-\ angiomyolipoma\ \(35\)\
\-\ angiomyolipoma\ \(35\)\
\-\ renal\\ cell\\ cancer\ \(1\)\
\-\ 54\\ female\\ with\\ questionable\\ renal\\ lesion\\ on\\ outside\\ ultrasound\\.\ \(0\)\
\-\ angiomyolipoma\\ \\(aml\\)\\ is\\ a\\ benign\\,\\ well\\ marginated\\,\\ nonencapsulated\\ hamartomatous\\ renal\\ neoplasm\\ composed\\ of\\ fat\\,\\ vascular\\,\\ and\\ smooth\\ muscle\\ elements\\.\\ most\\ extend\\ beyond\\ the\\ renal\\ capsule\\.\\ usually\\ solitary\\,\\ isolated\\ aml\\ is\\ more\\ common\\ in\\ women\\ of\\ childbearing\\ age\\.\ \(0\)\
\-\ fat\\ is\\ hypodense\\ on\\ ct\\ \\(hu\\ \\<\\ \\-\\ 50\\)\\,\\ hyperechoic\\ on\\ ultrasound\\,\\ and\\ hyperintense\\ on\\ mr\\ t1\\,\\ confirmed\\ with\\ fat\\ suppression\\.\\ demonstration\\ of\\ fatty\\ attenuation\\ in\\ a\\ renal\\ tumor\\ on\\ ct\\ is\\ virtually\\ diagnostic\\ of\\ an\\ aml\\.\\ \\ case\\ reports\\ exist\\ of\\ renal\\ cell\\ carcinomas\\ or\\ oncocytomas\\ with\\ engulfed\\ fat\\ that\\ appear\\ to\\ have\\ foci\\ of\\ fat\\ density\\ on\\ ct\\.\\ \\ nonfatty\\ amls\\ are\\ rare\\.\\ \\ if\\ calcification\\ present\\ consider\\ rcc\\.\\ \ \(0\)\
\-\ associations\\:\\ \\ \ \(0\)\
\-\ lymphangioleiomyomatosis\ \(13\)\
\-\ 40\\%\\ with\\ aml\\ have\\ tuberous\\ sclerosis\ \(0\)\
\-\ 80\\%\\ with\\ tuberous\\ sclerosis\\ have\\ aml\\,\\ multiple\\ and\\ bilateral\ \(0\)\
\-\ complications\\:\\ spontaneously\\ hemorrhage\\ or\\ hemorrhage\\ with\\ trauma\\,\\ may\\ be\\ massive\\.\\ \\ absence\\ of\\ elastic\\ tissue\\ in\\ the\\ tumor\\ vessels\\ predisposes\\ the\\ patient\\ to\\ aneurysm\\ formation\\ and\\ spontaneous\\ hemorrhage\\,\\ if\\ less\\ than\\ 4\\ cm\\ unlikely\\ to\\ hemorrhage\\.\\ large\\ or\\ symptomatic\\ lesions\\ are\\ resected\\ or\\ embolized\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aml\\:\\ 0\\.10358648017605479\ \(0\)\
\-\ fat\\:\\ 0\\.06360974216843159\ \(0\)\
\-\ renal\\:\\ 0\\.06284031065107162\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.05404150466262432\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.049724765457623006\ \(0\)\
\-\ embolized\\:\\ 0\\.03972044900725419\ \(0\)\
\-\ tuberous\\:\\ 0\\.032899612306246065\ \(0\)\
\-\ nonencapsulated\\:\\ 0\\.030823490992889856\ \(0\)\
\-\ engulfed\\:\\ 0\\.030823490992889856\ \(0\)\
\-\ resected\\:\\ 0\\.029584272344726756\ \(0\)\
\-\ unlikely\\:\\ 0\\.028465638430791945\ \(0\)\
\-\ nonfatty\\:\\ 0\\.0269821892842601\ \(0\)\
\-\ oncocytomas\\:\\ 0\\.025976307912051074\ \(0\)\
\-\ amls\\:\\ 0\\.025196085704658734\ \(0\)\
\-\ predisposes\\:\\ 0\\.02455859774384071\ \(0\)\
\-\ if\\:\\ 0\\.02432248357112555\ \(0\)\
\-\ childbearing\\:\\ 0\\.02401960935283631\ \(0\)\
\-\ symptomatic\\:\\ 0\\.023741142830029455\ \(0\)\
\-\ hamartomatous\\:\\ 0\\.023552716371631685\ \(0\)\
\-\ associations\\:\\ 0\\.023140887575630344\ \(0\)\
\-\ elastic\\:\\ 0\\.023140887575630344\ \(0\)\
\-\ perirenal\\:\\ 0\\.022439241787301147\ \(0\)\
\-\ lymphangioleiomyomatosis\\:\\ 0\\.02159601781241692\ \(0\)\
\-\ sclerosis\\:\\ 0\\.02146374289109332\ \(0\)\
\-\ or\\:\\ 0\\.02101096676147638\ \(0\)\
\-\ exist\\:\\ 0\\.02052824980699321\ \(0\)\
\-\ suppression\\:\\ 0\\.020348902623819956\ \(0\)\
\-\ less\\:\\ 0\\.020237342687571207\ \(0\)\
\-\ rcc\\:\\ 0\\.020178307644206556\ \(0\)\
\-\ large\\:\\ 0\\.01960009543878755\ \(0\)\
\-\ macroscopic\\:\\ 0\\.019431545055751804\ \(0\)\
\-\ have\\:\\ 0\\.019410189633200264\ \(0\)\
\-\ hu\\:\\ 0\\.01929958586700059\ \(0\)\
\-\ demonstration\\:\\ 0\\.01929958586700059\ \(0\)\
\-\ carcinomas\\:\\ 0\\.01917242627199753\ \(0\)\
\-\ virtually\\:\\ 0\\.018931192455609588\ \(0\)\
\-\ displaces\\:\\ 0\\.01859794007867139\ \(0\)\
\-\ hypodensity\\:\\ 0\\.01839220406460519\ \(0\)\
\-\ marginated\\:\\ 0\\.018293704494791566\ \(0\)\
\-\ composed\\:\\ 0\\.018293704494791566\ \(0\)\
\-\ exophytic\\:\\ 0\\.018197903885742214\ \(0\)\
\-\ ultrasound\\:\\ 0\\.017728129965079043\ \(0\)\
\-\ heterogeneously\\:\\ 0\\.017592058706462365\ \(0\)\
\-\ beyond\\:\\ 0\\.017361436441456084\ \(0\)\
\-\ massive\\:\\ 0\\.017075848920427177\ \(0\)\
\-\ questionable\\:\\ 0\\.0168759943265812\ \(0\)\
\-\ spontaneously\\:\\ 0\\.0168759943265812\ \(0\)\
\-\ ct\\:\\ 0\\.016717533613874725\ \(0\)\
\-\ 4\\:\\ 0\\.016650153183070247\ \(0\)\
\-\ elements\\:\\ 0\\.016392951185039882\ \(0\)\
\-\ consider\\:\\ 0\\.01622773130794007\ \(0\)\
\-\ capsule\\:\\ 0\\.016174348538252\ \(0\)\
\-\ cell\\:\\ 0\\.01614154343763277\ \(0\)\
\-\ cm\\:\\ 0\\.01602766515955934\ \(0\)\
\-\ lesions\\:\\ 0\\.015996926617789845\ \(0\)\
\-\ hypodense\\:\\ 0\\.0159190158983398\ \(0\)\
\-\ 54\\:\\ 0\\.015774312345322825\ \(0\)\
\-\ than\\:\\ 0\\.01565768430012779\ \(0\)\
\-\ isolated\\:\\ 0\\.01554570129894922\ \(0\)\
\-\ fatty\\:\\ 0\\.015501719542981176\ \(0\)\
\-\ corresponding\\:\\ 0\\.01520842764095075\ \(0\)\
\-\ on\\:\\ 0\\.01518652473493905\ \(0\)\
\-\ extend\\:\\ 0\\.014975241016829517\ \(0\)\
\-\ hyperechoic\\:\\ 0\\.014937844901036694\ \(0\)\
\-\ solitary\\:\\ 0\\.014827998061059845\ \(0\)\
\-\ women\\:\\ 0\\.014517759894595915\ \(0\)\
\-\ stranding\\:\\ 0\\.014452402786161812\ \(0\)\
\-\ enhances\\:\\ 0\\.014113268989003388\ \(0\)\
\-\ 80\\:\\ 0\\.014054992581712437\ \(0\)\
\-\ spontaneous\\:\\ 0\\.013941275128196495\ \(0\)\
\-\ \\%\\:\\ 0\\.013939307925496558\ \(0\)\
\-\ tumor\\:\\ 0\\.01393169441685882\ \(0\)\
\-\ pole\\:\\ 0\\.013913414395157414\ \(0\)\
\-\ kidneys\\:\\ 0\\.013750756997832613\ \(0\)\
\-\ regions\\:\\ 0\\.01367218057876947\ \(0\)\
\-\ smooth\\:\\ 0\\.013078128002561787\ \(0\)\
\-\ foci\\:\\ 0\\.01282525855647918\ \(0\)\
\-\ \\-\\:\\ 0\\.012809289921037506\ \(0\)\
\-\ parenchyma\\:\\ 0\\.012725065354519822\ \(0\)\
\-\ 40\\:\\ 0\\.012570498597511096\ \(0\)\
\-\ outside\\:\\ 0\\.012532901423468221\ \(0\)\
\-\ mid\\:\\ 0\\.012495704226947048\ \(0\)\
\-\ absence\\:\\ 0\\.012422476346369275\ \(0\)\
\-\ hyperintense\\:\\ 0\\.012404406520640454\ \(0\)\
\-\ formation\\:\\ 0\\.012333046829622248\ \(0\)\
\-\ appear\\:\\ 0\\.012228665839588398\ \(0\)\
\-\ are\\:\\ 0\\.012218956704855963\ \(0\)\
\-\ lesion\\:\\ 0\\.012171714867136047\ \(0\)\
\-\ reports\\:\\ 0\\.012045036349086838\ \(0\)\
\-\ vessels\\:\\ 0\\.012028811245742423\ \(0\)\
\-\ attenuation\\:\\ 0\\.012012661085405728\ \(0\)\
\-\ diagnostic\\:\\ 0\\.011839765017524677\ \(0\)\
\-\ complications\\:\\ 0\\.011839765017524677\ \(0\)\
\-\ aneurysm\\:\\ 0\\.011809227674976584\ \(0\)\
\-\ rare\\:\\ 0\\.011602623072284253\ \(0\)\
\-\ \\<\\:\\ 0\\.01153169764860766\ \(0\)\
\-\ 50\\:\\ 0\\.011367125932320995\ \(0\)\
\-\ \\,\\:\\ 0\\.011358464287438632\ \(0\)\
\-\ incidental\\:\\ 0\\.011313946146784182\ \(0\)\
\-\ confirmed\\:\\ 0\\.011235662947855935\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.01098669635243009\ \(0\)\
\-\ iv\\:\\ 0\\.01090358369741641\ \(0\)\
\-\ calcification\\:\\ 0\\.010845404260339612\ \(0\)\
\-\ n\\/a\\:\\ 0\\.010822400864891911\ \(0\)\
\-\ muscle\\:\\ 0\\.01073187144554666\ \(0\)\
\-\ kidney\\:\\ 0\\.010525816276398635\ \(0\)\
\-\ benign\\:\\ 0\\.010311364919696508\ \(0\)\
\-\ neoplasm\\:\\ 0\\.0101753726430487\ \(0\)\
\-\ density\\:\\ 0\\.009830878870139717\ \(0\)\
\-\ is\\:\\ 0\\.009830258363369329\ \(0\)\
\-\ cancer\\:\\ 0\\.009822256169107571\ \(0\)\
\-\ vascular\\:\\ 0\\.009796514922810128\ \(0\)\
\-\ finding\\:\\ 0\\.009629585681952732\ \(0\)\
\-\ mr\\:\\ 0\\.009493704447365154\ \(0\)\
\-\ t1\\:\\ 0\\.009470264112672181\ \(0\)\
\-\ image\\:\\ 0\\.009332829252788813\ \(0\)\
\-\ age\\:\\ 0\\.009094092047357715\ \(0\)\
\-\ usually\\:\\ 0\\.009073175712820836\ \(0\)\
\-\ focal\\:\\ 0\\.008533194420064342\ \(0\)\
\-\ axial\\:\\ 0\\.008527242923314237\ \(0\)\
\-\ through\\:\\ 0\\.008485863700772268\ \(0\)\
\-\ trauma\\:\\ 0\\.008171359376775976\ \(0\)\
\-\ \\:\\:\\ 0\\.007904019692242413\ \(0\)\
\-\ common\\:\\ 0\\.007819116125721668\ \(0\)\
\-\ more\\:\\ 0\\.007472644438154427\ \(0\)\
\-\ to\\:\\ 0\\.00746622567208018\ \(0\)\
\-\ none\\:\\ 0\\.007411606667510512\ \(0\)\
\-\ bilateral\\:\\ 0\\.007251110941658895\ \(0\)\
\-\ tissue\\:\\ 0\\.007081892267316761\ \(0\)\
\-\ without\\:\\ 0\\.0070350110711823784\ \(0\)\
\-\ most\\:\\ 0\\.006898024971077189\ \(0\)\
\-\ well\\:\\ 0\\.0067590243110791995\ \(0\)\
\-\ present\\:\\ 0\\.006748282356404478\ \(0\)\
\-\ contrast\\:\\ 0\\.006688026876950718\ \(0\)\
\-\ may\\:\\ 0\\.006553595695447985\ \(0\)\
\-\ case\\:\\ 0\\.006536728786249198\ \(0\)\
\-\ demonstrates\\:\\ 0\\.006526647558227923\ \(0\)\
\-\ multiple\\:\\ 0\\.006293027984193248\ \(0\)\
\-\ female\\:\\ 0\\.006142518431635782\ \(0\)\
\-\ in\\:\\ 0\\.00589366755440916\ \(0\)\
\-\ that\\:\\ 0\\.005160771778177704\ \(0\)\
\-\ \\(\\:\\ 0\\.00505148060310392\ \(0\)\
\-\ \\)\\:\\ 0\\.004989774070722413\ \(0\)\
\-\ be\\:\\ 0\\.004607540990713039\ \(0\)\
\-\ there\\:\\ 0\\.004446557889737723\ \(0\)\
\-\ the\\:\\ 0\\.004350501966198015\ \(0\)\
\-\ a\\:\\ 0\\.004160137781313999\ \(0\)\
\-\ mass\\:\\ 0\\.004155458066250226\ \(0\)\
\-\ an\\:\\ 0\\.004131695329666888\ \(0\)\
\-\ of\\:\\ 0\\.0040735594684611345\ \(0\)\
\-\ and\\:\\ 0\\.0037764127076689185\ \(0\)\
\-\ left\\:\\ 0\\.0033430254170381635\ \(0\)\
\-\ with\\:\\ 0\\.003272844086430482\ \(0\)\
\-\ patient\\:\\ 0\\.002995076681525832\ \(0\)\
\-\ \\.\\:\\ 0\\.0019859880334179734\ \(0\)\
